Oligonucleotide therapeutics infographic | Thermo Fisher Scientific

Oligonucleotide therapeutics have attracted much attention recently. They represent an up-and-coming class of therapeutic options that can lead to major advances in the treatment or cure of diseases, holding great potential for further development in human medicine.

Access the infographic to learn about:

Common types of oligonucleotide therapeutics
Milestones in oligonucleotide therapeutics
Main differences between ASOs and siRNAs
Oligonucleotide research areas for therapeutic development
Phosphoramidites in the development of oligonucleotide therapeutics
Future of oligonucleotide therapeutics

First name

Last name

Name of institution

Telephone

City

What type of oligos are you working on for oligo therapeutics development? (check all that apply)*

Antisense oligos (ASOs)

Aptamers

Guide RNAs (gRNAs)

Small activating RNAs (saRNAs)

Small interfering RNAs (siRNAs)

Other

I give consent to the Thermo Fisher Scientific group, its affiliates, any of its authorized distributors and agents (“Thermo Fisher Scientific”) to contact me via e-mail, phone calls and other communication methods to inform me of events, services and promotions which Thermo Fisher Scientific believes may be of interest and are useful to me. I am aware that I can withdraw consent by communicating my withdrawal to Thermo Fisher Scientific, including unsubscribing at any time by clicking on the “Unsubscribe” button in any of the emails I receive. I acknowledge that Thermo Fisher will process my Personal Information in accordance with its Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.